CHAPTER IV POST-MARKETING AUTHORISATION MEASURES
- 60Variations
- 61Variations that do not require assessment
- 62Application for variations requiring assessment
- 63Consequential changes to product information
- 64Groups of variations
- 65Work-sharing procedure
- 66Procedure for variations requiring assessment
- 67Measures to close the procedure for variations requiring assessment
- 68Implementation of variations requiring assessment
- 69Scope of the harmonisation of summaries of product characteristics of a veterinary medicinal product
- 70Procedure for harmonisation of summaries of product characteristics for the reference veterinary medicinal
- 71Procedure for harmonisation of summaries of product characteristics for generic and hybrid veterinary medic
- 72Environmental safety documentation and environmental risk assessment of certain veterinary medicinal produc
- 73Union pharmacovigilance system
- 74Union pharmacovigilance database
- 75Access to the pharmacovigilance database
- 76Reporting and recording of suspected adverse events
- 77Pharmacovigilance responsibilities of the marketing authorisation holder
- 78Qualified person responsible for pharmacovigilance
- 79Pharmacovigilance responsibilities of the competent authorities and the Agency
- 80Delegation of tasks by competent authority
- 81Signal management process
Source: EU legislation in force, consolidated versions and treaties (Cellar, Publications Office). Official publication. Reuse: Reuse authorised (Commission Decision 2011/833/EU).